In the clinic for July 23, 2026
AI Briefing
- Arrowhead Pharmaceuticals announces data readout for its RIN2 treatment for cancer.
- Arsenal Pharmaceuticals publishes new study on its AR-101 treatment for prostate cancer.
- Suzhou Ribo Life Science publishes data on its Ribozyme technology for cancer treatment.
Source Summary
Clinical updates for biopharma and med tech, including data readouts and publications: Arrowhead, Arsenal, Celldex, Curis, D&D, Gilead, Merck, Natera, Radiopharm, Summit, Suzhou Ribo Life Science.
Advertisement